Edition:
India

Bio Rad Laboratories Inc (BIO.N)

BIO.N on New York Stock Exchange

345.24USD
20 Sep 2019
Change (% chg)

$5.51 (+1.62%)
Prev Close
$339.73
Open
$342.16
Day's High
$345.61
Day's Low
$342.16
Volume
198,897
Avg. Vol
43,780
52-wk High
$345.61
52-wk Low
$220.10

Latest Key Developments (Source: Significant Developments)

Bio-Rad Files New Lawsuit Against 10X Genomics For Patent Infringement
Thursday, 12 Sep 2019 

Sept 11 (Reuters) - Bio Rad Laboratories Inc ::BIO-RAD FILES NEW LAWSUIT AGAINST 10X GENOMICS FOR PATENT INFRINGEMENT.BIO RAD LABORATORIES INC - IS SEEKING ALL AVAILABLE REMEDIES AGAINST 10X GENOMICS, INCLUDING DAMAGES AND INJUNCTIVE RELIEF.BIO RAD - IN LAWSUIT, CO ASSERTS 10X GENOMICS INFRINGES PATENT WHICH COVERS TECHNIQUES FOR DETECTING ENZYMATIC REACTIONS IN MICROFLUIDIC DROPLETS.  Full Article

Bio-Rad Posts Q2 EPS Of $19.86
Friday, 2 Aug 2019 

Aug 1 (Reuters) - Bio Rad Laboratories Inc ::BIO-RAD REPORTS SECOND-QUARTER 2019 FINANCIAL RESULTS.Q2 NON-GAAP EARNINGS PER SHARE $1.57.Q2 EARNINGS PER SHARE $19.86.Q2 SALES $572.6 MILLION VERSUS REFINITIV IBES ESTIMATE OF $566.2 MILLION.Q2 EARNINGS PER SHARE ESTIMATE $1.34 -- REFINITIV IBES DATA.FOR FY 2019, COMPANY CONTINUES TO ANTICIPATE CURRENCY-NEUTRAL REVENUE GROWTH OF APPROXIMATELY 4.0 TO 4.5%.  Full Article

Bio-Rad Reports Q1 Earnings Per Share $28.74
Thursday, 9 May 2019 

May 8 (Reuters) - Bio Rad Laboratories Inc ::BIO-RAD REPORTS FIRST QUARTER 2019 FINANCIAL RESULTS.Q1 NON-GAAP EARNINGS PER SHARE $1.65.Q1 EARNINGS PER SHARE $28.74.Q1 SALES $554 MILLION VERSUS REFINITIV IBES ESTIMATE OF $549.6 MILLION.Q1 EARNINGS PER SHARE ESTIMATE $1.11 -- REFINITIV IBES DATA.FOR FY 2019, COMPANY CONTINUES TO ANTICIPATE CURRENCY-NEUTRAL REVENUE GROWTH OF APPROXIMATELY 4.0 TO 4.5 PERCENT.  Full Article

Bio Rad Laboratories Files For Non-Timely 10-K - SEC Filing
Friday, 2 Mar 2018 

March 2 (Reuters) - Bio Rad Laboratories Inc ::BIO RAD LABORATORIES FILES FOR NON-TIMELY 10-K - SEC FILING.  Full Article

Bio-Rad Authorizes New $250 Million Share Repurchase Program
Tuesday, 28 Nov 2017 

Nov 28 (Reuters) - Bio Rad Laboratories Inc ::BIO-RAD AUTHORIZES NEW $250 MILLION SHARE REPURCHASE PROGRAM.BIO RAD LABORATORIES INC - ‍NEW SHARE REPURCHASE PROGRAM SUPERSEDES COMPANY'S PRIOR SHARE REPURCHASE PROGRAM​.  Full Article

Bio Rad Laboratories reports Q3 earnings per share $0.91
Friday, 3 Nov 2017 

Nov 2 (Reuters) - Bio Rad Laboratories Inc :Bio Rad Laboratories Inc reports third-quarter 2017 financial results.Q3 earnings per share $0.91.Q3 sales $535 million versus I/B/E/S view $508 million.Sees q4 2017 sales $615 million to $625 million.Q3 earnings per share view $0.38 -- Thomson Reuters I/B/E/S.  Full Article

CORRECTED-(OFFICIAL)-BRIEF-Bio-Rad Posts Q2 EPS Of $19.86 (Aug. 1)

* Q2 SALES $572.6 MILLION VERSUS REFINITIV IBES ESTIMATE OF $566.2 MILLION